Forvis Mazars Wealth Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,989
| Closed | -$138K | – | 397 |
|
|
2023
Q4 | $138K | Hold |
2,989
| – | – | ﹤0.01% | 382 |
|
|
2023
Q3 | $122K | Hold |
2,989
| – | – | ﹤0.01% | 383 |
|
|
2023
Q2 | $145K | Hold |
2,989
| – | – | ﹤0.01% | 401 |
|
|
2023
Q1 | $147K | Hold |
2,989
| – | – | ﹤0.01% | 400 |
|
|
2022
Q4 | $151K | Hold |
2,989
| – | – | 0.01% | 380 |
|
|
2022
Q3 | $150K | Buy |
+2,989
| New | +$150K | 0.01% | 378 |
|